Furthermore, miR-155 induces B-cell lymphoma cell proliferation and inhibits cell apoptosis by targeting nuclear interactors of ARF (alternative reading frame product of the INK4a/ARF locus) and MDM2 (mouse double minute 2) (NIAM) [144]. Here, CDKN2A is linked to B-cell non-Hodgkin lymphoma.